These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 15608695)
1. Quassinoids can induce mitochondrial membrane depolarisation and caspase 3 activation in human cells. Rosati A; Quaranta E; Ammirante M; Turco MC; Leone A; De Feo V Cell Death Differ; 2004 Dec; 11 Suppl 2():S216-8. PubMed ID: 15608695 [No Abstract] [Full Text] [Related]
2. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines. Izeradjene K; Douglas L; Tillman DM; Delaney AB; Houghton JA Cancer Res; 2005 Aug; 65(16):7436-45. PubMed ID: 16103097 [TBL] [Abstract][Full Text] [Related]
3. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways. Shankar S; Singh TR; Fandy TE; Luetrakul T; Ross DD; Srivastava RK Int J Mol Med; 2005 Dec; 16(6):1125-38. PubMed ID: 16273296 [TBL] [Abstract][Full Text] [Related]
4. Impaired activation of caspases and prevention of mitochondrial dysfunction in the metastatic colon carcinoma CC531s-m2 cell line. Velthuis JH; Gavric Z; de Bont HJ; Nagelkerke JF Biochem Pharmacol; 2005 Feb; 69(3):463-71. PubMed ID: 15652237 [TBL] [Abstract][Full Text] [Related]
5. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094 [TBL] [Abstract][Full Text] [Related]
7. 1-Methoxy-canthin-6-one induces c-Jun NH2-terminal kinase-dependent apoptosis and synergizes with tumor necrosis factor-related apoptosis-inducing ligand activity in human neoplastic cells of hematopoietic or endodermal origin. Ammirante M; Di Giacomo R; De Martino L; Rosati A; Festa M; Gentilella A; Pascale MC; Belisario MA; Leone A; Turco MC; De Feo V Cancer Res; 2006 Apr; 66(8):4385-93. PubMed ID: 16618764 [TBL] [Abstract][Full Text] [Related]
8. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death. Lawrence CP; Chow SC FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096 [TBL] [Abstract][Full Text] [Related]
10. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Shiraishi T; Yoshida T; Nakata S; Horinaka M; Wakada M; Mizutani Y; Miki T; Sakai T Cancer Res; 2005 Jul; 65(14):6364-70. PubMed ID: 16024639 [TBL] [Abstract][Full Text] [Related]
11. Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells. Lashinger LM; Zhu K; Williams SA; Shrader M; Dinney CP; McConkey DJ Cancer Res; 2005 Jun; 65(11):4902-8. PubMed ID: 15930312 [TBL] [Abstract][Full Text] [Related]
12. E1A sensitizes cancer cells to TRAIL-induced apoptosis through enhancement of caspase activation. Shao R; Lee DF; Wen Y; Ding Y; Xia W; Ping B; Yagita H; Spohn B; Hung MC Mol Cancer Res; 2005 Apr; 3(4):219-26. PubMed ID: 15831675 [TBL] [Abstract][Full Text] [Related]
13. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Sylvester PW; Shah S Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643 [TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135 [TBL] [Abstract][Full Text] [Related]
15. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis. Kim HS; Chang I; Kim JY; Choi KH; Lee MS Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612 [TBL] [Abstract][Full Text] [Related]
16. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells. Shi RX; Ong CN; Shen HM Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950 [TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-related apoptosis-inducing ligand alters mitochondrial membrane lipids. Sandra F; Degli Esposti M; Ndebele K; Gona P; Knight D; Rosenquist M; Khosravi-Far R Cancer Res; 2005 Sep; 65(18):8286-97. PubMed ID: 16166305 [TBL] [Abstract][Full Text] [Related]
19. Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria. Gao X; Deeb D; Jiang H; Liu YB; Dulchavsky SA; Gautam SC J Exp Ther Oncol; 2005; 5(1):39-48. PubMed ID: 16416600 [TBL] [Abstract][Full Text] [Related]
20. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells. Hyer ML; Croxton R; Krajewska M; Krajewski S; Kress CL; Lu M; Suh N; Sporn MB; Cryns VL; Zapata JM; Reed JC Cancer Res; 2005 Jun; 65(11):4799-808. PubMed ID: 15930300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]